193 related articles for article (PubMed ID: 20551373)
1. Blood eicosapentaenoic and docosahexaenoic acids predict all-cause mortality in patients with stable coronary heart disease: the Heart and Soul study.
Pottala JV; Garg S; Cohen BE; Whooley MA; Harris WS
Circ Cardiovasc Qual Outcomes; 2010 Jul; 3(4):406-12. PubMed ID: 20551373
[TBL] [Abstract][Full Text] [Related]
2. Red blood cell docosahexaenoic acid and eicosapentaenoic acid concentrations are positively associated with socioeconomic status in patients with established coronary artery disease: data from the Heart and Soul Study.
Cohen BE; Garg SK; Ali S; Harris WS; Whooley MA
J Nutr; 2008 Jun; 138(6):1135-40. PubMed ID: 18492846
[TBL] [Abstract][Full Text] [Related]
3. Omega-3 fatty acids and mortality in patients referred for coronary angiography. The Ludwigshafen Risk and Cardiovascular Health Study.
Kleber ME; Delgado GE; Lorkowski S; März W; von Schacky C
Atherosclerosis; 2016 Sep; 252():175-181. PubMed ID: 27397734
[TBL] [Abstract][Full Text] [Related]
4. Erythrocyte omega-3 fatty acids increase and linoleic acid decreases with age: observations from 160,000 patients.
Harris WS; Pottala JV; Varvel SA; Borowski JJ; Ward JN; McConnell JP
Prostaglandins Leukot Essent Fatty Acids; 2013 Apr; 88(4):257-63. PubMed ID: 23375840
[TBL] [Abstract][Full Text] [Related]
5. The Omega-3 Index and relative risk for coronary heart disease mortality: Estimation from 10 cohort studies.
Harris WS; Del Gobbo L; Tintle NL
Atherosclerosis; 2017 Jul; 262():51-54. PubMed ID: 28511049
[TBL] [Abstract][Full Text] [Related]
6. Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events: the Kuopio ischaemic heart disease risk factor study.
Rissanen T; Voutilainen S; Nyyssönen K; Lakka TA; Salonen JT
Circulation; 2000 Nov; 102(22):2677-9. PubMed ID: 11094031
[TBL] [Abstract][Full Text] [Related]
7. Blood eicosapentaenoic acid and docosahexaenoic acid as predictors of all-cause mortality in patients with acute myocardial infarction--data from Infarction Prognosis Study (IPS) Registry.
Lee SH; Shin MJ; Kim JS; Ko YG; Kang SM; Choi D; Jang Y; Chung N; Shim WH; Cho SY; Manabe I; Ha JW
Circ J; 2009 Dec; 73(12):2250-7. PubMed ID: 19789416
[TBL] [Abstract][Full Text] [Related]
8. Intake of total omega-3 fatty acids, eicosapentaenoic acid and docosahexaenoic acid and risk of coronary heart disease in the Spanish EPIC cohort study.
Amiano P; Machón M; Dorronsoro M; Chirlaque MD; Barricarte A; Sánchez MJ; Navarro C; Huerta JM; Molina-Montes E; Sánchez-Cantalejo E; Urtizberea M; Arriola L; Larrañaga N; Ardanaz E; Quirós JR; Moreno-Iribas C; González CA
Nutr Metab Cardiovasc Dis; 2014 Mar; 24(3):321-7. PubMed ID: 24360762
[TBL] [Abstract][Full Text] [Related]
9. Blood docosahexaenoic acid and eicosapentaenoic acid in vegans: Associations with age and gender and effects of an algal-derived omega-3 fatty acid supplement.
Sarter B; Kelsey KS; Schwartz TA; Harris WS
Clin Nutr; 2015 Apr; 34(2):212-8. PubMed ID: 24679552
[TBL] [Abstract][Full Text] [Related]
10. Plasma eicosapentaenoic acid is negatively associated with all-cause mortality among men and women in a population-based prospective study.
Miura K; Hughes MCB; Ungerer JP; Green AC
Nutr Res; 2016 Nov; 36(11):1202-1209. PubMed ID: 27865614
[TBL] [Abstract][Full Text] [Related]
11. Long-term fish consumption and n-3 fatty acid intake in relation to (sudden) coronary heart disease death: the Zutphen study.
Streppel MT; Ocké MC; Boshuizen HC; Kok FJ; Kromhout D
Eur Heart J; 2008 Aug; 29(16):2024-30. PubMed ID: 18641046
[TBL] [Abstract][Full Text] [Related]
12. Absolute versus relative measures of plasma fatty acids and health outcomes: example of phospholipid omega-3 and omega-6 fatty acids and all-cause mortality in women.
Miura K; Hughes MCB; Ungerer JPJ; Smith DD; Green AC
Eur J Nutr; 2018 Mar; 57(2):713-722. PubMed ID: 27995316
[TBL] [Abstract][Full Text] [Related]
13. Plasma levels of n-3 fatty acids and risk of coronary heart disease among Japanese: The Japan Public Health Center-based (JPHC) study.
Hamazaki K; Iso H; Eshak ES; Ikehara S; Ikeda A; Iwasaki M; Hamazaki T; Tsugane S;
Atherosclerosis; 2018 May; 272():226-232. PubMed ID: 29277442
[TBL] [Abstract][Full Text] [Related]
14. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.
Kragelund C; Grønning B; Køber L; Hildebrandt P; Steffensen R
N Engl J Med; 2005 Feb; 352(7):666-75. PubMed ID: 15716560
[TBL] [Abstract][Full Text] [Related]
15. Association between ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cardiovascular disease: the Hisayama Study.
Ninomiya T; Nagata M; Hata J; Hirakawa Y; Ozawa M; Yoshida D; Ohara T; Kishimoto H; Mukai N; Fukuhara M; Kitazono T; Kiyohara Y
Atherosclerosis; 2013 Dec; 231(2):261-7. PubMed ID: 24267237
[TBL] [Abstract][Full Text] [Related]
16. Positive affect and survival in patients with stable coronary heart disease: findings from the Heart and Soul Study.
Hoen PW; Denollet J; de Jonge P; Whooley MA
J Clin Psychiatry; 2013 Jul; 74(7):716-22. PubMed ID: 23945449
[TBL] [Abstract][Full Text] [Related]
17. The omega-3 index in patients with heart failure: A prospective cohort study.
Berliner D; Mattern S; Wellige M; Malsch C; Güder G; Brenner S; Morbach C; Deubner N; Breunig M; Kiefl R; Angermann CE; Ertl G; von Schacky C; Störk S
Prostaglandins Leukot Essent Fatty Acids; 2019 Jan; 140():34-41. PubMed ID: 30553401
[TBL] [Abstract][Full Text] [Related]
18. Blood omega-3 and trans fatty acids in middle-aged acute coronary syndrome patients.
Harris WS; Reid KJ; Sands SA; Spertus JA
Am J Cardiol; 2007 Jan; 99(2):154-8. PubMed ID: 17223410
[TBL] [Abstract][Full Text] [Related]
19. Altered Serum n-6 Polyunsaturated Fatty Acid Profile and Risks of Mortality and Cardiovascular Events in a Cohort of Hemodialysis Patients.
Kuwamura Y; Shoji T; Okute Y; Yamazaki Y; Motoyama K; Morioka T; Mori K; Fukumoto S; Tsujimoto Y; Shioi A; Emoto M; Inaba M
J Ren Nutr; 2018 Jan; 28(1):54-63. PubMed ID: 29089279
[TBL] [Abstract][Full Text] [Related]
20. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease.
Whooley MA; de Jonge P; Vittinghoff E; Otte C; Moos R; Carney RM; Ali S; Dowray S; Na B; Feldman MD; Schiller NB; Browner WS
JAMA; 2008 Nov; 300(20):2379-88. PubMed ID: 19033588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
